Vin Singh, Founder and CEO of BullFrog AI, a precision medicine company, discusses their bfLEAP Platform and how leveraging the power of AI and machine learning can quickly digest and analyze large sets of data and reveal insights about treatment response against patient populations which will improve selection for clinical trials and boost success rates.
Vin Singh, Founder and CEO BullFrog AI
Founder & former CEO, Next Healthcare Inc.
Co-founder, MaxCyte Inc. – Nasdaq (MXCT) – $1.5B market cap
Global Director, Cell Therapy – ThermoFisher Scientific
B.S. Electrical Engineering, Rutgers University
M.S. Biomedical Engineering, Rensselaer Polytechnic Institute
MBA, The Johns Hopkins University